BEAM-MM - β-Hydroxybutyrate-Enhanced Adaptive Immunity in Multiple Myeloma
Clinical trial NCT07564219 · RECRUITING
Trial details
- NCT number
- NCT07564219
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2027-12-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.